BrightSpring Health Services (NASDAQ: BTSG) insider transactions
In the twelve months to 10 November 2026, executives and directors of BrightSpring Health Services reported 12 open-market sales of 69,399,641 shares ($3,362m) and 0 open-market purchases, by 8 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 25 October 2026 | Rousseau Jon B | See Remarks | Shares withheld for tax | −36,355 | $60.11 | 1,101,829 | Form 4 |
| 14 September 2026 | Greenwell Scott A. | President, PharMerica | Option exercise, 10b5-1 plan | +11,973 | $22.27 | 46,345 | Form 4 |
| 14 September 2026 | Greenwell Scott A. | President, PharMerica | Open-market sale, 10b5-1 plan | −15,099 | $57.91 | 31,246 | Form 4 |
| 25 July 2026 | Rousseau Jon B | See Remarks | Shares withheld for tax | −56,319 | $72.91 | 1,138,184 | Form 4 |
| 20 June 2026 | Greenwell Scott A. | President, PharMerica | Shares withheld for tax | −2,487 | $66.25 | 34,372 | Form 4 |
| 11 June 2026 | Shah Nigam H. | Director | Grant or award | +4,013 | — | 4,013 | Form 4 |
| 5 June 2026 | Phipps Jennifer A | Chief Financial Officer | Option exercise | +35,000 | $6.37 | 285,224 | Form 4 |
| 5 June 2026 | Phipps Jennifer A | Chief Financial Officer | Open-market sale | −35,000 | $58.75 | 250,224 | Form 4 |
| 5 June 2026 | Nalley Lisa A | See Remarks | Option exercise | +35,000 | $6.37 | 166,948 | Form 4 |
| 5 June 2026 | Nalley Lisa A | See Remarks | Open-market sale | −35,000 | $58.75 | 131,948 | Form 4 |
| 5 June 2026 | Rousseau Jon B | See Remarks | Option exercise | +130,000 | $6.37 | 1,324,503 | Form 4 |
| 5 June 2026 | Rousseau Jon B | See Remarks | Open-market sale | −130,000 | $58.75 | 1,194,503 | Form 4 |
| 5 June 2026 | Rousseau Jon B | See Remarks | Option exercise | +130,000 | $6.37 | 130,000 | Form 4 |
| 5 June 2026 | Rousseau Jon B | See Remarks | Open-market sale | −130,000 | $58.75 | 0 | Form 4 |
| 5 June 2026 | KKR Associates Americas XII L.P. | — | Open-market sale | −14,669,771 | $58.45 | 27,154,488 | Form 4 |
| 5 June 2026 | KKR Associates Americas XII L.P. | — | Other | −324,608 | — | 26,829,880 | Form 4 |
| 5 June 2026 | KKR Associates Americas XII L.P. | — | Gift | −36,927 | — | 0 | Form 4 |
| 5 June 2026 | KKR Associates Americas XII L.P. | — | Gift | −23,263 | — | 0 | Form 4 |
| 5 June 2026 | Kravis Henry R | — | Open-market sale | −14,669,771 | $58.45 | 27,154,488 | Form 4 |
| 5 June 2026 | Kravis Henry R | — | Other | −324,608 | — | 26,829,880 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the BrightSpring Health Services page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.